Navigation Links
Aida Pharmaceuticals, Inc. Announces Completion of Research Institute Acquisition
Date:4/24/2008

SANTA MONICA, Calif., April 24 /PRNewswire-FirstCall/ -- Aida Pharmaceuticals, Inc. (OTC Bulletin Board: AIDA) today announced that it has completed the acquisition of a controlling interest in Jiangsu Institute of Microbiology Co., Ltd. ("JSIM"), one of the leading microbiology research institutes in the People's Republic of China. JSIM has several drugs currently undergoing clinical testing and has new products in its development pipeline. This acquisition is expected to add several new products to Aida Pharmaceutical Inc.'s existing line of products, thus diversifying its product mix and enabling the Company to increase its market share in the PRC pharmaceutical market.

The controlling interest in JSIM was acquired through two of Aida Pharmaceutical Inc.'s subsidiaries, namely Hangzhou Aida Pharmaceutical Co., Ltd. (which acquired a 43% equity interest) and Changzhou Fangyuan Pharmaceutical Co., Ltd. (which acquired a 55% equity interest).

JSIM is a national leader in microbiology with over thirty years of research history. It is located in Wuxi City in Jiangsu Province, has over thirty scientists and engineers that have completed over 200 research projects. Of these research projects, over twenty of them were developed as national-level key projects, as designated by the Chinese government. JSIM's research efforts have yielded numerous patents.

About Aida Pharmaceuticals, Inc.

Aida Pharmaceuticals, Inc. is a product-focused pharmaceuticals company engaged in the formulation, clinical testing, registration, manufacture, sales and marketing of advanced pharmaceutical and genetic products in mainland China. The Company's mission is to discover, develop and market meaningful new therapies that improve human health. Aida Pharmaceuticals, Inc., in operation since March 1999, is headquartered in Hangzhou, People's Republic of China with manufacturing, distribution and sales points throughout mainland China. Aida Pharmaceuticals, Inc.
'/>"/>

SOURCE Aida Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. GlaxoSmithKline to Acquire Sirtris Pharmaceuticals, a World Leader in Sirtuin Research and Development
2. Pacira Pharmaceuticals, Inc. Expands Development Collaborations for DepoFoam(R)
3. Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals, LLC
4. Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights
5. Aida Pharmaceuticals, Inc. Acquires High-Level Research Institute in the Peoples Republic of China
6. Jazz Pharmaceuticals, Inc. Announces Expansion of Senior Debt
7. ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
8. Jazz Pharmaceuticals, Inc. Announces Webcast of March 13 Investor Meeting
9. Acura Pharmaceuticals, Inc. Reports 2007 4th Quarter and Annual Financial Results; Sets 2008 Expectations
10. Investor Alert from Cauley Bowman Carney & Williams, PLLC: Update on Proposed Acquisition of CollaGenex Pharmaceuticals, Inc. - CGPI
11. Strativa Pharmaceuticals, a Division of Par Pharmaceutical, Announces the Discontinuation of the Development Program for Pafuramidine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2008)...IENNA, Va., Dec. 3 In re... Corporation (NYSE Alternext US: CVM) announced,t...manufacturing facility to,its website. The pictur...ttp://www.cel-sci.com ) by clicking on the link "U... special highlights section. , CEL-SCI is d...
(Date:12/3/2008)...NION CITY, Calif., Dec. 3 /PRNewswire-FirstCall/ -...cts company manufacturing point-of-care blood,ana..., CEO and President, will,participate in a panel ...n,Thursday, December 11, 2008 at 9:00 a.m. ET. Th...will be held at the Westin New York Times Square h...
(Date:12/3/2008)...EW YORK, Dec. 3 When it comes to t...y moms feel it,s their responsibility to be as,ed... the many different,medicines out there, it is ha...hat and the dangers of drug reactions, interaction...ewscom.com/cgi-bin/prnh/20081203/NYWFNS1 ) , ...
(Date:12/2/2008)... Scientists at Singapore,s Institute of Bioenginee...roperties of imidazolium salts (IMSs), which sugge...evention and treatment. , The report on the red...l of the American Chemical Society . , In a sepa...tional Edition , IBN researchers reported the firs...
Breaking Biology Technology:Family Medicine Cabinet: Free, New On-Line Tool Helps Track Your Medication Safety 2New uses for imidazolium salts in medicine and alternative energy 2New uses for imidazolium salts in medicine and alternative energy 3
...ou subscribe to the theory that consumer need is w...any may provide you with some proof. , ,In this c...net service or broadband access leave something to...ness designed to solve the riddle has deciphered w...Chiozzi, who plans to launch Broadband Infrastruc...
...ic Foundry, Inc. has closed a public offering of ...aised $11.25 million for general corporate purpose...g of common stock at $3.75 per share, marketed to ...tion statement previously filed with the Securiti...ch develops a rich-media product called MediaSite,...
...recommendations of a state technology organization...e tax-credit program designed to encourage more in...nheeded due to the state,s fiscal situation and ph... according to state officials. , ,In a recently pu...ncil called for removing investment limits in the...
...obbyists from AT&T and BellSouth must simply b...he band back together and no one can stop them. , ...ll off the largest telecom merger in U.S. history....tter as one big company. They are another step clo...ined the Revestiture of AT&T in a column in May 20...
Other Biology Technology:Company to operate in wireless Internet space 2Will there be more money for investment credits? 2AT&T - BellSouth merger: Revestiture continues 2AT&T - BellSouth merger: Revestiture continues 3AT&T - BellSouth merger: Revestiture continues 4AT&T - BellSouth merger: Revestiture continues 5AT&T - BellSouth merger: Revestiture continues 6
(Date:12/3/2008)...e gene into mouse blood cells, scientists at St. J...ickle cell disease pathology. In their studies, th...ssentially no difference from normal mice. Althoug...erapy to humans presents significant technical obs...ome an important treatment for the disease. , Si...
(Date:12/3/2008)... technique using lasers could be employed to measu...supports one of the main objectives of the candida...vanced Space Carbon and climate Observation of Pla...rer missions that has just completed assessment st...e, will be presented to the science community at a...
(Date:12/3/2008)...International Society for Stem Cell Research (ISSC...of stem cell researchers, released new guidelines ...ive stem cell therapies for patients. A Commentary...inical Translation of Stem Cells will be published... Cell , the official affiliated journal of the ISS...
(Date:12/3/2008)...or pregnancy - other asthma drugs have not been as...using the same asthma drugs they were using before... studied and can be regarded as safe. More trials .... According to the German Institute for Quality an...m trials could reassure women who worry about the ...
Breaking Biology News(10 mins):Gene therapy corrects sickle cell disease in laboratory study 2Gene therapy corrects sickle cell disease in laboratory study 3ESA tests laser to measure atmospheric carbon dioxide 2ESA tests laser to measure atmospheric carbon dioxide 3The International Society for Stem Cell Research releases new guidelines 2The International Society for Stem Cell Research releases new guidelines 3Pregnant women with asthma can be more confident about some medicines 2Report says half a million cancer deaths have been averted since death rate drop 12309 1Report says half a million cancer deaths have been averted since death rate drop 12309 2Report says half a million cancer deaths have been averted since death rate drop 12309 3Report says half a million cancer deaths have been averted since death rate drop 12309 4Report says half a million cancer deaths have been averted since death rate drop 12309 5U S Cancer Deaths Down But Far Too Few Americans Screened for Colon Cancer 12307 1U S Cancer Deaths Down But Far Too Few Americans Screened for Colon Cancer 12307 2U S Cancer Deaths Down But Far Too Few Americans Screened for Colon Cancer 12307 3U S Cancer Deaths Down But Far Too Few Americans Screened for Colon Cancer 12307 4Federal nanotech risk research plan still comes up short 3406 1Federal nanotech risk research plan still comes up short 3406 2Directed self ordering of organic molecules for electronic devices 3403 1Directed self ordering of organic molecules for electronic devices 3403 2
...researchers have learned how to selectively shut d...a heavyweight punch, a discovery that may help doc...ther health problems. , The finding, which will be...he National Academy of Sciences, deals with tiny s...ce thought to be little more than cellular debris,...
... the international, open-access journal PLoS Medi...a newly identified virus and the pediatric respira...eir recent description of the coronavirus HCoV-NL6... one of the most frequently detected viruses in ch...TIs). These infections are estimated by the World ...
...from the Department of Biochemistry and Molecular ...niversitat Autònoma de Barcelona has discovered th...xtremely useful as a therapy against psychological...a, and to slow the progress of neurodegenerative d...xin is a neurotoxin belonging to the same family a...
...Medicine researchers first to discover that a prot...licationSince the discovery of the structure of DN...aradigm for DNA replication has stated that the DN...plication. , In other words, if a guanine base is ...cytosine base, will pair to it on the replicated s...
Other Biology News:Micro-molecule plays big role in birth defects 2A novel virus for croup 2Tetanus toxin found to have therapeutic properties 2
The Econo gradient pump rack is a preassembled rack that is used to hold the components of the Econo gradient pump kits.
...84-well reaction module is used for nucleic acid a...th an interchangeable, 384-well reaction module (5...perature monitoring and control and ramp rates tha...des the iCycler base with 384-well reaction module...
The DNA Engine instrument is the cycler that revolutionized thermal cycling. Unprecedented thermal uniformity and swappable blocks ensure consistent results, experiment-to-experiment and block-to-b
The Gene Pulser Xcell microbial system, 100 to 240 V, 50-60 Hz, is used for electroporation of bacterial and fungal cells. This system includes the main unit, PC module for exponential decay delivery
Biology Products: